We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Adocia Signs an Exclusive License on a Nanotechnology

News   Dec 09, 2013

 
Adocia Signs an Exclusive License on a Nanotechnology
 
 
 

RELATED ARTICLES

Antibiotics Generated from Wasp Venom

News

Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.

READ MORE

Innovative Sensor Could Improve Food Safety

News

A new sensor design could one day make it easier to detect pathogens in food before products hit the supermarket shelves, thus preventing sometimes-deadly illnesses from contaminated food.

READ MORE

Emerging Strategies for Treating Opioid-use Disorder

News

Anti-opioid immunopharmacotherapies (e.g., conjugate vaccines) that sequester drug peripherally, preventing opioids from reaching targeted receptors in the brain, have recently emerged as promising therapeutics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE